Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.
about
Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual careA novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsRacial, gender, and socioeconomic status bias in senior medical student clinical decision-making: a national survey.Data-driven Decisions: The Importance of Clinical Trials in Arrhythmia Management.Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.Challenges of prescribing low-dose drug therapy for older people.The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators.Consequences of variation in treatment for acute myocardial infarction.Choosing quality of care measures based on the expected impact of improved care on health.β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study.Defining the utility of clinically acceptable variations in evidence-based practice guidelines for evaluation of quality improvement activities.Secondary prevention in acute myocardial infarction.Nonacute coronary syndrome anginal chest pain.Randomised trials of secondary prevention programmes in coronary heart disease: systematic reviewPremature Ventricular Contractions and Non-sustained Ventricular Tachycardia: Association with Sudden Cardiac Death, Risk Stratification, and Management StrategiesGuidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.Treatment of refractory anginaSelf-controlled case-series study to verify the effect of adherence to Beta-blockers in secondary prevention of myocardial infarctionMedical treatment after myocardial infarction. Results of studies using various methods.Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study.Beta-blocker underuse in secondary prevention of myocardial infarction.Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocol.From cardiac repair to cardiac regeneration--ready to translate?Myocardial infarction. Considerations for geriatric patients.Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention.Patterns and determinants of cardiovascular drug utilization in coronary care unit patients of a tertiary care hospital.Treatment strategies for chronic stable angina.Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.Antagonist molecules in the treatment of anginaAcute myocardial infarction. Treatment in the coronary care unitAnti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.Acute myocardial infarction. The race to the hospital.Secondary prevention in coronary heart disease: baseline survey of provision in general practice.An update on management of the patient presenting with non-ST-elevation acute coronary syndromes.Adjunctive medications in patients receiving thrombolytic therapy: a multicenter prospective assessment. The Virginia Multicenter Thrombolytic Study Group.Dysrhythmias in acute myocardial infarction: how to treat, when to treat, and when not to treat.Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pUtility of beta-blockade treatment for older postinfarction patients.
P2860
Q28217493-0C44984F-5A98-400C-9A99-70C150CD4F73Q28472432-0BD87B7F-E42F-4C3C-8725-6B66FED90D09Q30358565-A51FB41D-4DE6-4C88-A937-61E9062815E1Q33179799-B0207B0A-7106-4059-AE0E-48A508A13EC3Q33590391-CD011AC8-2DD8-4468-931B-77B8CA353952Q33596150-5EFA8087-6A5E-4224-9860-B4B5C6F555D8Q33686584-8EB01C9B-0975-43F0-B2BF-88BF6A5785EAQ33718012-4A18FCE5-BEAA-45E2-9FEC-454741E10ED9Q33725005-8FF893FA-59F6-425E-83F9-01D71CFAF0BCQ33758547-B55A6575-BFA6-4D05-A6D7-83B2C113070CQ33764581-599B922E-07CE-4594-8268-6EB18F97FC35Q33772069-50F0253F-68A5-471A-9EA1-88E6EFD13218Q33789369-F8993C53-8D6D-4E22-8654-E7746DCE922EQ33878551-FC39E6B5-520A-4574-B6FE-63108C71B8F3Q33944137-4BAEFF42-EB12-4BC8-AD23-981978129189Q34070684-8974AAA4-261D-4030-B007-E6DDBCA5DC13Q34103716-0CF2C82A-E6E7-4371-9670-06D5A15AFD2CQ34986448-6D2A2F4B-551F-4218-B00D-09065618196AQ35088189-24E3979A-1526-4D96-8FB0-FDB0FF5FD9E9Q35272535-D07A9F04-61CB-4D06-9A1C-5E162BA5DE5DQ35559410-80D1866E-1435-4110-AA54-F2ACD2CCD011Q35637982-C51EA91B-B1FF-445C-BB2B-01326DFEE1DDQ35855776-7B60967E-90EC-4167-B7B0-582DA13F37E4Q36569726-34B5DBB0-4C87-4734-B44D-BDE7023810E9Q36653476-B0D4373C-5980-4B15-9D56-2FA9AF087049Q37402737-87E7E58E-6C00-4620-BD89-43D9E4D72929Q37628382-3C867C64-C1DF-4705-A2EE-879B6DA8F2E0Q37636450-6392D116-DF99-492C-9D35-48970427A227Q37958035-38C1D1BE-DEF8-48F2-8852-62846371DCB6Q37964807-21AD0DAE-6A13-4829-AF29-150CB44FC112Q38139089-1AE5A04D-B088-40EF-9895-2A5F34CD810FQ38248767-FC03FE04-D67E-4A78-8ED7-8C85C919DA71Q38394310-BCBA0D34-7B59-435D-AAE3-CB36AE169369Q38601742-F28603C7-CB63-4A17-89BE-0435F7B62DECQ38644473-63D75EE7-FEF4-414A-A234-12E1282F8A8EQ38813299-D61F6D57-C45B-474D-A9D0-0F75D2771633Q39228697-8F0E6903-B322-4E10-9900-E9DF765A0285Q40493090-FCD42EC8-C4E8-48C5-9B8D-D19ECF6325F3Q41082977-86A01BDF-996E-43A0-9C70-44C541B8ECB7Q41674409-2915FAE4-4ED1-4440-A7D9-24083CAF379A
P2860
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Overview of results of randomi ...... llowing myocardial infarction.
@en
Overview of results of randomi ...... llowing myocardial infarction.
@nl
type
label
Overview of results of randomi ...... llowing myocardial infarction.
@en
Overview of results of randomi ...... llowing myocardial infarction.
@nl
prefLabel
Overview of results of randomi ...... llowing myocardial infarction.
@en
Overview of results of randomi ...... llowing myocardial infarction.
@nl
P2093
P1476
Overview of results of randomi ...... llowing myocardial infarction.
@en
P2093
P304
P356
10.1001/JAMA.1988.03410140100032
P407
P577
1988-10-01T00:00:00Z